Aging of preleukemic thymocytes drives CpG island hypermethylation in T-cell acute lymphoblastic leukemia.
MetadataShow full item record
Cancer cells display DNA hypermethylation at specific CpG islands in comparison to their normal healthy counterparts, but the mechanism that drives this so-called CpG island methylator phenotype (CIMP) remains poorly understood. Here, we show that CpG island methylation in human T-cell acute lymphoblastic leukemia (T-ALL) mainly occurs at promoters of Polycomb Repressor Complex 2 (PRC2) target genes that are not expressed in normal or malignant T-cells and which display a reciprocal association with H3K27me3 binding. In addition, we revealed that this aberrant methylation profile reflects the epigenetic history of T-ALL and is established already in pre-leukemic, self-renewing thymocytes that precede T-ALL development. Finally, we unexpectedly uncover that this age-related CpG island hypermethylation signature in T-ALL is completely resistant to the FDA-approved hypomethylating agent Decitabine. Altogether, we here provide conceptual evidence for the involvement of a pre-leukemic phase characterized by self-renewing thymocytes in the pathogenesis of human T-ALL.
Showing items related by title, author, creator and subject.
Molecular mechanism underlying aberrant expression of the connective tissue growth factor in paediatric pre-B cell acute lymphoblastic leukemiaWelch, Mathew D. (2011)Acute lymphoblastic leukaemia (ALL) is the most common cancer diagnosed in children aged 1-14 years. There have been vast improvements in clinical outcomes for children diagnosed with ALL with cure rates of up to 90% ...
Maunakea, A.; Nagarajan, R.; Bilenky, M.; Ballinger, T.; Dsouza, C.; Fouse, S.; Johnson, B.; Hong, C.; Nielsen, C.; Zhao, Y.; Turecki, G.; Delaney, A.; Varhol, Richard; Thiessen, N.; Shchors, K.; Heine, V.; Rowitch, D.; Xing, X.; Fiore, C.; Schillebeeckx, M.; Jones, S.; Haussler, D.; Marra, M.; Hirst, M.; Wang, T.; Costello, J. (2010)Although it is known that the methylation of DNA in 5' promoters suppresses gene expression, the role of DNA methylation in gene bodies is unclear. In mammals, tissue-and cell type-specific methylation is present in a ...
RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemia.Matthijssens, Filip; Sharma, Nitesh D; Nysus, Monique; Nickl, Christian K; Kang, Huining; Perez, Dominique R; Lintermans, Beatrice; Van Loocke, Wouter; Roels, Juliette; Peirs, Sofie; Demoen, Lisa; Pieters, Tim; Reunes, Lindy; Lammens, Tim; De Moerloose, Barbara; Van Nieuwerburgh, Filip; Deforce, Dieter L; Cheung, Laurence ; Kotecha, Rishi ; Risseeuw, Martijn DP; Van Calenbergh, Serge; Takarada, Takeshi; Yoneda, Yukio; van Delft, Frederik W; Lock, Richard B; Merkley, Seth D; Chigaev, Alexandre; Sklar, Larry A; Mullighan, Charles G; Loh, Mignon L; Winter, Stuart S; Hunger, Stephen P; Goossens, Steven; Castillo, Eliseo F; Ornatowski, Wojciech; Van Vlierberghe, Pieter; Matlawska-Wasowska, Ksenia (2021)T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematologic malignancy with inferior outcome compared to B-cell ALL. Here, we showed that Runt-related transcription factor 2, RUNX2 was upregulated in high-risk ...